2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $2.8B | $2.9B | $3.3B | $3.1B | $3.6B |
Cost of Revenue | $679M | $874M | $1B | $927M | $823M |
Gross Profit | $2.1B | $2B | $2.2B | $2.2B | $2.8B |
Gross Profit % | 76% | 70% | 69% | 70% | 77% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $517M | $944M | $1.3B | $999M | $1.6B |
Dep. & Amort. | $491M | $552M | $582M | $601M | $650M |
Def. Tax | $3.3M | -$9.8M | $2M | $1M | $14M |
Stock Comp. | $15M | $28M | $28M | $32M | $37M |
Chg. in WC | $30M | $216M | -$49M | -$79M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $445M | $202M | $287M | $273M | $1.1B |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $445M | $202M | $287M | $273M | $1.1B |
Receivables | $471M | $467M | $590M | $681M | $721M |
Inventory | $882K | $3.4M | $3.8M | $2.6M | $2.5M |
Wesfarmers reported growth in sales, earnings, and dividends despite challenging market conditions, with a fully franked dividend of $0.95 per share, a 4.1% increase from the prior period.
Key divisions like Bunnings and Kmart Group performed strongly, driven by productivity initiatives, value-focused strategies, and digital transformation efforts, while the health division showed progress in consumer segments but faced supply chain cost pressures.
The company highlighted significant portfolio actions, including the sale of Corgas for $770 million and the wind-down of Catch, which is expected to improve earnings in FY 2026.
Investments in technology and supply chain improvements continue, with net capital expenditure for FY 2024 expected to be between $1.1 billion and $1.3 billion, while maintaining a strong balance sheet with net financial debt reduced by $400 million.
The lithium hydroxide project remains on track for first production in mid-2025, with ramp-up expected over 18 months, though profitability in FY 2026 is unlikely due to early-stage costs.